opens new tab said on Friday the European Patent ... COVID shot Comirnaty after suing them in 2022 for allegedly copying its mRNA technology. Pfizer and BioNTech have countersued, alleging that ...
Moderna MRNA-Q said on Friday the European Patent Office had upheld the validity of one of the company’s key patents, a win in an ongoing COVID-19 vaccine dispute with Pfizer PFE-N and BioNTech ...
Synopsys VC Verification IP (VIP) for Fibre Channel is designed to thoroughly verify Fibre Channel designs using both random and directed simulation. The Fibre Channel VIP provides full protocol ...
Moderna Inc. gained US approval for its RSV vaccine in older adults, giving the biotech company a second product as it seeks to move beyond its reliance on the fading market for Covid-19 shots ...
The approval is a big moment for Moderna, which previously only had just one product, its COVID shot. Like rival Pfizer, Moderna’s stock price has plunged as the world moves on from the pandemic.
Moderna Inc.’s respiratory syncytial virus vaccine for older adults received U.S. regulatory approval, the company said Friday, marking the first time a messenger RNA vaccine has been approved ...
The approval is a big moment for Moderna, which previously only had just one product, its Covid shot. Like rival Pfizer, Moderna’s stock price has plunged as the world moves on from the pandemic. The ...
A researcher at the Moderna headquarters in Cambridge, Mass. (Adam Glanzman/Bloomberg News) Moderna, the biotech that rose to fame for making one of the world’s first Covid-19 vaccines ...
Reuters, the news and media division of Thomson Reuters, is the world’s largest multimedia news provider, reaching billions of people worldwide every day. Reuters provides business, financial ...